R. Oliver

R. Oliver, M. Sobeh, A. Paris, 1994, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Germ cell cancer.

R. Oliver, R. Oliver, 1999, Current opinion in oncology.

Unexplained spontaneous regression and alpha-interferon as treatment for metastatic renal carcinoma.

R. Oliver, J. Bottomley, A. Nethersell, 1989, British journal of urology.

A phase 2 study of Cis-platinum in patients with recurrent bladder carcinoma. The London and Oxford Co-operative Urological Cancer Group.

E. Newlands, J. Malpas, R. Oliver, 1981, British journal of urology.

Current opinion in germ cell cancer 2000.

R. Oliver, R. Oliver, 2000, Current opinion in oncology.

Combined seminoma/non-seminoma should be considered as intermediate grade germ cell cancer (GCC).

M. Leahy, R. Oliver, J. Ong, 1995, European journal of cancer.

Pilot studies of 2 and 1 course carboplatin as adjuvant for stage I seminoma: should it be tested in a randomized trial against radiotherapy?

M. Williams, J. Ong, C. Wiltshire, 1994, International journal of radiation oncology, biology, physics.

A phase 2 study of surveillance in patients with metastatic renal cell carcinoma and assessment of response of such patients to therapy on progression.

R. Oliver, M. Barnett, A. Mehta, 1988, Molecular biotherapy.

Postchemotherapy Residual Masses in Germ Cell Tumor Patients. Content, Clinical Features, and Prognosis

S. Fosså, A. Horwich, C. Fisher, 1999 .

Radiotherapy after chemotherapy for metastatic seminoma--a diminishing role. MRC Testicular Tumour Working Party.

A. Horwich, G. Rustin, S. Kaye, 1997, European journal of cancer.

Findings in lymph nodes of patients with germ cell tumours after chemotherapy and their relation to prognosis.

J. Martin, S. Baithun, R. Oliver, 1989, Journal of clinical pathology.

HISTOPATHOLOGY IN THE PREDICTION OF RELAPSE OF PATIENTS WITH STAGE I TESTICULAR TERATOMA TREATED BY ORCHIDECTOMY ALONE

L. Freedman, E. Newlands, M. Peckham, 1987, The Lancet.

Possible new approaches to the management of seminoma of the testis.

R. Oliver, H. Hope‐Stone, J. Blandy, 1984, British journal of urology.

Diagnosis and management of extragonadal germ cell tumours

R. Oliver, S. Vijayaraghavan, 1994 .

Clues from natural history and results of treatment supporting the monoclonal origin of germ cell tumours.

R. Oliver, 1990, Cancer surveys.

Short-course etoposide, bleomycin and cisplatin in the treatment of metastatic germ cell tumours. Appraisal of its potential as adjuvant chemotherapy for stage 1 testis tumours.

R. Oliver, H. Hope‐Stone, J. Blandy, 1988, British journal of urology.

The relevance of p53 mutation in urological malignancies: possible clinical implications for bladder cancer.

A. Nouri, H. Cannell, R. Oliver, 1996, British journal of urology.

A randomised comparison of single agent carboplatin with radiotherapy in the adjuvant treatment of stage I seminoma of the testis, following orchidectomy: MRC TE19/EORTC 30982.

G. Rustin, G. Mead, P. Ell, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A Medical Research Council randomized trial of single agent carboplatin versus etoposide and cisplatin for advanced metastatic seminoma

S. Fosså, D. Dearnaley, A. Horwich, 2000, British Journal of Cancer.

The familial influence on bilateral testicular germ cell cancer: Medical Research Council study TER2.

A. Horwich, G. Mead, G. Daugaard, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A lesson in the management of testicular cancer in a patient with a solitary testis

R. Oliver, J. Tobias, D. Badenoch, 1999, Postgraduate medical journal.

Limitations to the use of surveillance as an option in the management of stage I seminoma.

R. Oliver, 1987, International journal of andrology.

D. Dearnaley, A. Horwich, R. Sylvester, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prognostic factors for patients with advanced seminoma treated with platinum-based chemotherapy.

S. Fosså, A. Horwich, S. Kaye, 1997, European journal of cancer.

Renal cell cancer: is there long-term survival advantage from cytokine treatment?

R. Oliver, 1994, European journal of cancer.

Alternatives to radiotherapy in the management of seminoma.

J. Ong, R. Oliver, S. Lore, 1990, British journal of urology.

Prebiopsy neo-adjuvant endocrine therapy for breast cancer to prevent post-surgery trauma-induced growth factor and immune-suppression mediated tumour progression.

R. Oliver, J. Tobias, C. Gallagher, 1996, European journal of cancer.

Does surgery disseminate or accelerate cancer?

R. Oliver, 1995, The Lancet.

Influence of HL-A matching antigenic strength, and immune responsiveness on outcome of 349 cadaver renal grafts. 3 years' experience of the London transplant group.

J. Moorhead, R. Oliver, R. Oliver, 1972, Lancet.

New views on rejection mechanisms and their relevance to interleukin-2 as a treatment for renal cell cancer.

R. Oliver, 1991, European journal of cancer.

Human chorionic gonadotrophin expression and histological findings as predictors of response to radiotherapy in carcinoma of the bladder

J. Martin, S. Baithun, R. Oliver, 2004, Virchows Archiv A.

T cell immune response to cancer in humans and its relevance for immunodiagnosis and therapy.

A. Nouri, R. Oliver, 1992, Cancer surveys.

Malignant germ cell tumours in the elderly: a histopathological review of 50 cases in men aged 60 years or over

D. Berney, D. Neal, T. Powles, 2008, Modern Pathology.

T3 bladder cancer: salvage rather than elective cystectomy after radiotherapy.

R. Oliver, H. Hope‐Stone, J. Blandy, 1984, Urology.

Methotrexate in the treatment of metastatic and recurrent primary transitional cell carcinoma.

R. Oliver, R. Risdon, J. Blandy, 1984, The Journal of urology.

Castration-induced lymphocytosis in prostate cancer: possible evidence for gonad/thymus endocrine interaction in man.

R. Oliver, C. Gallagher, J. V. Joseph, 1995, Urologia internationalis.

Current Controversies in the Management of Testicular Germ Cell Tumors

R. Oliver, H. Hope‐Stone, J. Blandy, 1985 .

Testicular Microlithiasis: Is It a Benign Condition with Malignant Potential?

R. Oliver, J. Webb, D. Badenoch, 2001, European Urology.

Radical retroperitoneal node dissection after chemotherapy for testicular tumours.

R. Oliver, J. Blandy, B. Jenkins, 1989, British journal of urology.

Preservation of sexual function after salvage retroperitoneal node dissection following chemotherapy for testicular tumors

R. Oliver, J. Blandy, B. Jenkins, 1992, World Journal of Urology.

Serologically undetectable immune responses in transplantation.

R. Oliver, H. Festenstein, J. Sachs, 1972, Transplantation proceedings.

Serologically defined HL-A antigens and long-term survival of cadaver kidney transplants. A joint analysis of 918 cases performed by France-Transplant and the London Transplant Group.

J Dausset, J. Dausset, M. Busson, 1974, The New England journal of medicine.

International collaboration in renal transplantation.

J. Moorhead, R. Oliver, M. Bewick, 1971, Lancet.

Multicentre collaboration in 162 tissue-typed renal transplants. The London and Regional Transplant Group, March, 1969, to December, 1970.

J. Moorhead, R. Oliver, G. Pegrum, 1971, Lancet.

COMPOSITION OF INTACT HORMONE AND FREE SUBUNITS IN THE HUMAN CHORIONIC GONADOTROPHIN‐LIKE MATERIAL FOUND IN SERUM AND URINE OF PATIENTS WITH CARCINOMA OF THE BLADDER

T. Chard, R. Oliver, R. Iles, 1990, Clinical endocrinology.

Serum and tissue tumour markers in seminomas.

J. Masters, R. Oliver, D. Butcher, 1985, British journal of urology.

Rare cancers and specialist centres.

R. Oliver, 1986, British medical journal.

Justification of the use of surveillance in the management of Stage I germ cell tumours of the testis.

R. Oliver, H. Hope‐Stone, J. Blandy, 1983, British Journal of Urology.

International germ cell consensus classification: A prognostic factor-erased staging system for metastatic germ cell cancers

Richard Sylvester, Andrew Kramar, Madhu Mazumdar, 1997 .

The association between intratubular seminoma and invasive germ cell tumors.

D. Berney, J. Shamash, R. Oliver, 2006, Human pathology.

The Frequency and Distribution of Intratubular Trophoblast in Association With Germ Cell Tumors of the Testis

D. Berney, J. Shamash, R. Oliver, 2005, The American journal of surgical pathology.

The frequency of intratubular embryonal carcinoma: implications for the pathogenesis of germ cell tumours

D. Berney, J. Shamash, S. Jordan, 2004, Histopathology.

Prognostic factors for renal cell carcinoma.

P. Royston, T. Eisen, P. Harnden, 2008, Cancer treatment reviews.

Randomized trial of carboplatin versus radiotherapy for stage I seminoma: mature results on relapse and contralateral testis cancer rates in MRC TE19/EORTC 30982 study (ISRCTN27163214).

G. Rustin, G. Mead, R. Coleman, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The Atrophy Hypothesis and Development of Malignant Germ Cell Cancers of the Testis

R. Oliver, 2002 .

Clinicopathological significance of immunoreactive beta-hCG production by bladder cancer.

R. Oliver, C. Stephenson, M. Parkinson, 1988, Molecular biotherapy.

TERTIARY ONCOLOGY CENTRES

R. Oliver, J. Pritchard, 1985, The Lancet.

Chemotherapy of metastatic testicular tumours.

P. Wrigley, J. Malpas, R. Oliver, 1980, British journal of urology.

Prediction of response to radiotherapy in invasive bladder cancer.

J. Martin, S. Baithun, R. Oliver, 1990, British journal of urology.

Adjuvant Cis vs. carboplatin for stage I seminoma

R. Oliver, 1994 .

Tumors of the Testicle: Recent Advances in Diagnosis

R. Oliver, J. Blandy, W. Hately, 1985 .

Orchidopexy and transformation of seminoma to non-seminoma

R. Oliver, M. Raja, J. Blandy, 1992, The Lancet.

Diagnosis of metastases from testicular germ cell tumours using fine needle aspiration cytology.

R. Oliver, W. Highman, R T Oliver, 1987, Journal of clinical pathology.

Alternatives to Radiotherapy for Patients with Seminoma

R. Oliver, 1988 .

Comparison of the cytotoxic activities of chemotherapeutic drugs using a human bladder cancer cell line

B. Hill, P. Hepburn, J. Masters, 2004, Urological Research.

Major shifts in the treatment and prognosis of prostate cancer due to changes in pathological diagnosis and grading

J. Cuzick, D. Berney, M. Kattan, 2007, BJU international.

Randomized trials in 2466 patients with stage I seminoma: patterns of relapse and follow-up.

S. Fosså, R. Huddart, G. Mead, 2011, Journal of the National Cancer Institute.

Interferon-alpha and survival in metastatic renal carcinoma: early results of a randomised controlled trial

P. Fayers, S. Fosså, M. Parmar, 1999 .

Embolization and subsequent nephrectomy in metastatic renal cell carcinoma

K. Kurth, R. Oliver, C. Schulman, 2004, World Journal of Urology.

GERM CELL TUMOURS OF THE TESTICLE

D. Forman, J. Bodmer, W. Bodmer, 1986, Journal of immunogenetics.

Second, third locus and 4a/4b antigen associations in Negroids and Caucasoids.

R. Oliver, H. Festenstein, 1975, Tissue antigens.

A collaborative scheme for tissue typing and matching in renal transplantation. VI. Clinical relevance of HL-A matching in 349 cadaver renal transplants.

R. Oliver, H. Festenstein, J. Sachs, 1969, Transplantation proceedings.

Radiotherapy versus single-dose carboplatin in adjuvant treatment of stage I seminoma: a randomised trial

G. Rustin, R. Coleman, R. Wit, 2005, The Lancet.

p53 and MDM2 in germ cell cancer treatment response.

D. Berney, J. Shamash, R. Oliver, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Bladder Cancer. Principles of Combination Therapy

H. Bloom, W. Hendry, R. Oliver, 1981 .

Genetic Studies of the Mixed Lymphocyte Reaction in H-2 Identical Mice1

R. Oliver, H. Festenstein, J. Sachs, 1971 .

Pregnancy and breast cancer

R. Oliver, 1994, The Lancet.

The case for definitive radiotherapy and salvage cystectomy in localized bladder carcinoma

R. Tiptaft, R. Oliver, H. Hope‐Stone, 1985, World Journal of Urology.

Phase II study of VP 16-213 (etoposide) in metastatic transitional cell urothelial cancer

B. Ponder, R. Oliver, 2004, Cancer Chemotherapy and Pharmacology.

On the development of the Medical Research Council trial of alpha-interferon in metastatic renal carcinoma. Urological Working Party Renal Carcinoma Subgroup.

John Whitehead, Peter Fayers, David Machin, 1994, Statistics in medicine.

Reappraisal of the role of radiotherapy and surgery in the management of carcinoma of the penis.

R. Oliver, H. Hope‐Stone, J. Blandy, 1984, British journal of urology.

Testicular germcell tumours -amodel foranewapproach to treatment ofadult solid tumours

R. Oliver, 1985 .

Radiotherapy versus carboplatin for stage I seminoma: Updated analysis of the MRC/EORTC randomized trial (ISRCTN27163214)

G. Mead, P. Fogarty, S. Stenning, 2008 .

Medical options in the management of stages 1 and 2 (N0-N3, M0) testicular germ cell tumors.

L. Freedman, M. Peckham, R. Oliver, 1987, The Urologic clinics of North America.

Monoclonality of multiple bladder cancers.

R. Oliver, 1992, The New England journal of medicine.

Prognostic factors influencing survival of patients receiving intravesical epodyl.

J. Fitzpatrick, R. Oliver, P. Riddle, 1982, The Journal of urology.

Long-term follow-up in patients with superficial bladder tumours treated with intravesical Epodyl.

J. Fitzpatrick, R. Oliver, O. Khan, 1979, British journal of urology.

PSYCHOLOGICAL SUPPORT FOR CANCER PATIENTS

T. Kraft, R. Oliver, S. Chaturvedi, 1989, The Lancet.

Germ cell cancer of the testis.

R. Oliver, 1998, Current opinion in oncology.

Factors contributing to delay in diagnosis of testicular tumours.

R. Oliver, 1985, British medical journal.

The role of chemotherapy in the treatment of penile metastases from carcinoma of the bladder.

C. Woodhouse, R. Tiptaft, R. Oliver, 1987, European urology.

Are there Y‐linked histocompatibility antigens in man?

R. Oliver, R. Oliver, 1974, European journal of immunology.

Consensus on pathological classifications of testicular tumours.

F. Mostofi, K. Grigor, R. Oliver, 1990, Progress in clinical and biological research.

FSH in testis cancer. Re: Nord C, Bjøro T, Ellingsen D, Mykletun A, Dahl O, Klepp O, Bremnes RM, Wist E, Fosså SD. Gonadal hormones in long-term survivors 10 years after treatment for unilateral testicular cancer. Eur Urol 2003;44:322-8.

R. Oliver, 2004, European Urology.

Future trials in germ cell malignancy (GCM) of the testis.

R. Oliver, 1997, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

A phase II study of carboplatin in metastatic transitional cell carcinoma of the bladder

P. Wilkinson, L. Freedman, D. Newling, 1987 .

Endocrine hypothesis for declining sperm count and rising incidence of cancer

R. Oliver, J. Oliver, 1996, The Lancet.

Renal Cell Carcinoma: Clinical Aspects and Natural History

R. Oliver, J. Blandy, H. R. England, 1983 .

Long-term follow-up of Anglian Germ Cell Cancer Group surveillance versus patients with Stage 1 nonseminoma treated with adjuvant chemotherapy.

M. Williams, D. Neal, J. Shamash, 2004, Urology.

Screening for colorectal cancer

R. Oliver, H. Burns, 1993, The Lancet.

Prognostic factors in advanced non-seminomatous germ-cell testicular tumours: results of a multicentre study

K. Sikora, A. Horwich, P. Wilkinson, 1985 .